Research
External collaborations
Graft-versus-Host and Autoimmunity Unit, Experimental Transplantation and Immunology Branch National Institutes of Health, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, Dr S Pavletic.
Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA, Dr R Nash.
Department of Neurology, University of Genoa, Italy, Prof G L Mancardi.
Department of Hematology, Florence, Italy, Dr R Saccardi.
University of Texas at San Antonio, TX, USA, Dr Thomas Forsthuber.
Northwestern University, Chicago, IL, USA, Dr R Burt.
Johns Hopkins University, Baltimore, MD, USA, Dr P Calabresi, Dr D Kerr.
Fellowships
National Institutes of Health, USA, Fogarty Fellow. 1997 - 1998.
Italian Multiple Sclerosis Society, Fellow. 1995 - 1996.
Guest lectures
Therapeutic reconditioning of the immune system through hematopoietic stem cell transplantation. Institute for Neuroimmunology and Clinical Multiple Sclerosis Research (INiMS), Center for Molecular Neurobiology Hamburg, University Clinic Eppendorf, Hamburg, Germany. 2009.
Immune reconstitution - resetting the immune system. Annual Congress SGAI-SSAI /Spring Meeting SGDV-SSDV (Swiss Society for Allergology and Immunology), Basel, Switzerland. 2007.
Reconstitution of the immune repertoire and immune tolerance after HSCT. European Federation of Neurological Societies, Annual Meeting, Glasgow, UK. 2006.
Restoration of self tolerance in autoimmune disease by HSCT. European Group for Blood and Marrow Transplantation, Hamburg, Germany. 2006.
Immune reconstitution after hematopoietic stem cell transplantation. City of Hope Medical Center, International Symposium “Cellular Therapy for Treatment of Autoimmune Disease: Basic Science and Clinical Studies Meeting”, Newport Beach, CA, USA. 2005.
Repairing the immune system in multiple sclerosis. University of Bristol, Bristol. 2005.
Experimental Immunotherapies for multiple sclerosis. University of Nottingham, Nottingham. 2005.
The “immune resetting” hypothesis in hematopoietic stem cell transplantation as a therapy for multiple sclerosis. Thomas Jefferson University, Philadelphia, PA, USA. 2005.
Immune reconstitution after autologous hematopoietic stem cell transplantation for multiple sclerosis. Washington University, St Louis, Missouri, USA. 2004.
Disease-modifying treatments for multiple sclerosis. Department of Pathology, Case Western Reserve University, Cleveland, OH, USA. 2003.
Stem Cell Therapy for Tolerance and Tissue Regeneration. Cumming Foundation, Snowbird, UT, USA. 2002.
Immunotherapies for MS: from mechanisms of action to disease pathogenesis. University of Maryland, Baltimore, Maryland, USA. 2002.
T cell clonotype tracking: a highly specific window on the immune system. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States. 2001.
In search of “the bad cells” in multiple sclerosis; dissecting the human myelin-specific T cell repertoire. The Max Planck Institute for Neurobiology, Martinsried (Munich) Germany. 2000.
Unraveling naïve, memory and effector T cell responses to human myelin antigens. University of Siena, Siena, Italy. 2000.
Analysis of T cell receptor repertoire in immune-mediated disorders of the CNS. University of Florence, Florence, Italy. 1999.
The autoimmune hypothesis in multiple sclerosis: role of myelin antigen-specific T cell responses. The Mario Negri Sud Center for Pharmacological and Biomedical Research, S. Maria Imbaro, Italy. 1998.
Editorial boards
Faculty of 1000 Medicine, Associate Member, Neurological Disorders Section. 2008 -
